At Elekta, our purpose is to bring hope for everyone dealing with cancer. We envision a world where everyone has access to the best cancer care. Our mission is to improve patient lives by collaborating with our customers and partners.

As a leading innovator in precision radiation therapy solutions, Elekta is dedicated to ensuring every patient has access to the best cancer care possible. Our offerings enable clinicians to treat more patients with increased quality through innovative solutions and AI-supported services within a global network.

Our strategy, ACCESS 2025, focuses on closing the access gap, elevating cancer care, and increasing patient participation in their care journey. We aim to grow the installed base of radiation therapy machines in underserved markets, improve clinical adoption and utilization of new technology, and enhance patient involvement in their own care.

Through Elekta Kaiku, our personalized digital patient monitoring platform, we provide advanced digital solutions that optimize cancer care, support patient safety and treatment coordination, and generate real-world data for research and life sciences.

Elekta Kaiku enables co-creation with life science partners to develop therapy-specific modules, utilizing machine learning to predict patient symptoms and improve treatment outcomes.

Our platform delivers high patient satisfaction, efficient treatment coordination for cancer centers, and structured real-world data for research purposes.

Patients experience improved safety, reduced adverse events, and earlier detection of symptoms, enhancing overall cancer care quality.

Cancer centers benefit from focused patient interactions, earlier symptom interventions, and reduced call burdens on healthcare systems.

Life sciences research gains access to detailed patient-reported data and machine learning models capable of predicting treatment outcomes.